Yahoo Web Search

  1. The company announced Monday morning that it’s paying almost $11 billion for cancer drugmaker Array Biopharma Inc. The deal would bolster Pfizer’s cancer portfolio and add medicines that ...

  2. Big Drugmakers That May Tread the M&A Path After Pfizer

    Zacks via Yahoo FinanceJun 19 13:06 PM

    In a surprising move, on Monday, drug giant, Pfizer PFE announced a definitive agreement to buy small cancer drugmaker, Array BioPharma ARRY for $48 per share in cash for a total enterprise ...

  3. AstraZeneca plc. AZN and partner Merck MRK announced that the European Commission (EC) has granted marketing approval to their PARP inhibitor Lynparza for first-line maintenance treatment of BRCA-mutated advanced ovarian cancer.